Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2019-01-31 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MIREPOIX (09500), Ariege
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA PORTE D'AVAL : revenue, balance sheet and financial ratios
PHARMACIE DE LA PORTE D'AVAL is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MIREPOIX (09500),
this company of category PME
shows in 2022 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA PORTE D'AVAL (SIREN 847897873)
Indicator
2024
2023
2022
2021
2020
Revenue
N/C
N/C
2 136 799 €
N/C
N/C
Net income
88 591 €
128 695 €
188 061 €
196 645 €
104 026 €
EBITDA
N/C
N/C
204 988 €
N/C
N/C
Net margin
N/C
N/C
8.8%
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE LA PORTE D'AVAL generates positive net income of 89 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 104 k€ -> 89 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
88 591 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 61%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
60.868%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.266%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA PORTE D'AVAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
Debt ratio
427.021
205.526
129.174
78.584
60.868
Financial autonomy
16.398
29.462
39.184
49.786
56.266
Repayment capacity
None
None
4.053
None
None
Cash flow / Revenue
None%
None%
8.957%
None%
None%
Sector positioning
Debt ratio
60.872024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-12 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE LA PORTE D'AVAL (60.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
56.27%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+19 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE LA PORTE D'AVAL (56.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.05 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DE LA PORTE D'AVAL (4.05) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 327.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
327.002
Liquidity indicators evolution PHARMACIE DE LA PORTE D'AVAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
Liquidity ratio
186.347
299.72
355.498
281.729
327.002
Interest coverage
None
None
3.578
None
None
Sector positioning
Liquidity ratio
327.02024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of PHARMACIE DE LA PORTE D'AVAL (327.00) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.58x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of PHARMACIE DE LA PORTE D'AVAL (3.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA PORTE D'AVAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
166 927 €
0 €
0 €
Inventory turnover (days)
0
0
30
0
0
Customer payment term (days)
0
0
3
0
0
Supplier payment term (days)
0
0
20
0
0
Positioning of PHARMACIE DE LA PORTE D'AVAL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA PORTE D'AVAL is estimated at
1 236 795 €
(range 861 285€ - 1 850 317€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
861k€1236k€1850k€
1 236 795 €Range: 861 285€ - 1 850 317€
NAF 5 année 2024
Valuation method used
Net Income Multiple
88 591 €
×
14.0x
=1 236 796 €
Range: 861 285€ - 1 850 317€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA PORTE D'AVAL with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA PORTE D'AVAL
What is the revenue of PHARMACIE DE LA PORTE D'AVAL ?
The revenue of PHARMACIE DE LA PORTE D'AVAL in 2022 is 2.1 M€.
Is PHARMACIE DE LA PORTE D'AVAL profitable?
Yes, PHARMACIE DE LA PORTE D'AVAL generated a net profit of 89 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA PORTE D'AVAL ?
The headquarters of PHARMACIE DE LA PORTE D'AVAL is located in MIREPOIX (09500), in the department Ariege.
Where to find the tax return of PHARMACIE DE LA PORTE D'AVAL ?
The tax return of PHARMACIE DE LA PORTE D'AVAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA PORTE D'AVAL operate?
PHARMACIE DE LA PORTE D'AVAL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart